Expression Table for this CRE
| CNhs13823 | iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2 | 43.2 |
| CNhs13092 | mesenchymal precursor cell - ovarian cancer left ovary, donor2 | 13.8 |
| CNhs13469 | CD14+ monocytes - treated with Group A streptococci, donor1 | 8.0 |
| CNhs12996 | temporal lobe, fetal, donor1 | 7.5 |
| CNhs13845 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2 | 6.7 |
| CNhs13844 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2 | 6.2 |
| CNhs14525 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3 | 5.5 |
| CNhs14434 | COBL-a rinderpest infection, 48hr, biol_rep3 | 5.3 |
| CNhs14376 | mesothelioma cell line:Mero-14 | 5.0 |
| CNhs14241 | gastric cancer cell line:GSS | 4.4 |
| CNhs12705 | MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3 | 4.3 |
| CNhs12024 | Endothelial Cells - Microvascular, donor3 | 3.7 |
| LShi10008_ACAGTG-CACTAGT | Human induced pluripotent stem cells grown on feeder-free condition, biol_rep1 | 3.5 |
| CNhs12184 | CD8+ T Cells (pluriselect), donor090612, donation2 | 3.5 |
| CNhs12060 | Skeletal Muscle Cells, donor6 | 3.4 |
| CNhs11891 | hereditary spherocytic anemia cell line:WIL2-NS | 3.4 |
| CNhs12343 | CD19+ B Cells, donor1 | 3.3 |
| CNhi10789_ATG | Human primary dermal fibroblasts derived from neonatal foreskin, biol_rep3 | 3.3 |
| CNhs12041 | Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3 | 3.3 |
| CNhs12345 | Schwann Cells, donor2 | 3.2 |
| CNhs13551 | Mallassez-derived cells, donor3 | 3.2 |
| CNhs13379 | Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2) | 3.2 |
| CNhs14534 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3 | 3.0 |
| CNhs14599 | Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2 | 3.0 |
| CNhs14406 | 293SLAM rinderpest infection, 00hr, biol_rep1 | 3.0 |
| CNhi10941_GCT | Human primary dermal blood vascular endothelial cells, biol_rep2 | 3.0 |
| CNhs11889 | anaplastic squamous cell carcinoma cell line:RPMI 2650 | 3.0 |
| CNhs12797 | K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3 | 2.8 |
| CNhs13067 | mesothelioma cell line:Mero-41 | 2.7 |
| CNhs12810 | salivary acinar cells, donor1 | 2.7 |
| CNhs14539 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2 | 2.7 |
| CNhs14190 | Smooth muscle cells - airway, control, donor1 | 2.7 |
| CNhs13327 | Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3) | 2.6 |
| CNhs13326 | Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3) | 2.6 |
| CNhs14183 | Smooth muscle cells - airway, asthmatic, donor1 | 2.6 |
| CNhs14552 | medial temporal gyrus, adult, donor10258 | 2.6 |
| CNhs12702 | K562 erythroblastic leukemia response to hemin, day04, biol_rep2 | 2.6 |
| CNhs14543 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3 | 2.5 |
| CNhs12802 | K562 erythroblastic leukemia response to hemin, day02, biol_rep3 | 2.5 |
| CNhs12342 | Lens Epithelial Cells, donor1 | 2.5 |
| CNhs12026 | Endothelial Cells - Vein, donor3 | 2.4 |
| CNhs12522 | neutrophil PMN, donor1 | 2.4 |
| CNhs12920 | Fibroblast - Villous Mesenchymal, donor3 | 2.4 |
| CNhs14223 | thalamus, adult, donor10258 | 2.4 |
| CNhs13361 | Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11) | 2.4 |
| CNhs13380 | Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2) | 2.4 |
| CNhs11796 | brain, adult, donor1 | 2.4 |
| CNhs13831 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1 | 2.4 |
| CNhs14138 | bronchioalveolar carcinoma cell line:NCI-H650 | 2.3 |
| CNhs14532 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1 | 2.3 |